Bolt Biotherapeutics, Inc. Class Action
Robbins LLP is Investigating Allegations that Bolt Therapeutics, Inc. (BOLT) Misled Investors Regarding the Viability of its New Drug Candidate Robbins LLP informs investors that a shareholder filed a class action